Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - mycophenolate mofetil - film-coated tablet - mycophenolate mofetil 500 mg - immunosuppressants

Malta - English - Medicines Authority

accord healthcare limited - mycophenolate mofetil - hard capsule - mycophenolate mofetil 250 mg - immunosuppressants

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - mycophenolate mofetil, quantity: 250 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; microcrystalline cellulose; croscarmellose sodium; sodium lauryl sulfate; silicon dioxide; magnesium stearate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid; titanium dioxide; indigo carmine; iron oxide yellow; sorbitan monolaurate; iron oxide red; potable water; gelatin - ceptolate (mycophenolate mofetil) is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. ceptolate (mycophenolate mofetil) is indicated for the prophylaxis of organ rejection in paediatric patients with a body surface area of greater than or equal to 1.25 square metres, receiving allogeneic renal transplants.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - mycophenolate mofetil, quantity: 500 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; povidone; sodium lauryl sulfate; silicon dioxide; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - ceptolate (mycophenolate mofetil) is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. ceptolate (mycophenolate mofetil) is indicated for the prophylaxis of organ rejection in paediatric patients with a body surface area of greater than or equal to 1.25 square metres, receiving allogeneic renal transplants.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mycophenolate mofetil, quantity: 250 mg - capsule, hard - excipient ingredients: erythrosine; gelatin; povidone; microcrystalline cellulose; purified water; sodium lauryl sulfate; titanium dioxide; croscarmellose sodium; magnesium stearate; iron oxide yellow; butan-1-ol; shellac; industrial methylated spirit; iron oxide black; lecithin; xanthan gum; glyceryl monostearate; benzoic acid; methylcellulose; simethicone; glyceryl distearate; peg-10 stearate; sorbic acid; dimeticone 5000 - imulate is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. imulate is indicated for the prophylaxis of organ rejection in paediatric patients with a body surface area of greater than or equal to 1.25 meters square receiving allogeneic renal transplants (refer dosage and administration section).

United States - English - NLM (National Library of Medicine)

sandoz inc - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil 500 mg

United States - English - NLM (National Library of Medicine)

avpak - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil 500 mg

United States - English - NLM (National Library of Medicine)

greenstone llc - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil 500 mg

Malta - English - Medicines Authority

accord healthcare limited - mycophenolate mofetil - powder for concentrate for solution for infusion - mycophenolate mofetil 500 mg - immunosuppressants

Malta - English - Medicines Authority

accord healthcare limited - mycophenolate mofetil - film-coated tablet - mycophenolate mofetil 500 mg - immunosuppressants